Our observation provides a novel mechanism for enhanced inflammation at sites of disturbed flow and suggests that therapeutic targeting of the P2X7-calcium influx-p38 pathway may prevent or treat atherosclerosis. This evidence concerns the gene MAPK14 and atherosclerosis.